pyrene are the dihydrodiols involved, via the related vicinal diol-epoxides, in the metabolic activation of these hydrocarbons, mouse skin initiation-promotion experiments may be more useful for the identification of such diols than the other two in vivo tests for biological activity used here.
dimethylbenz [a] anthracene and 3-methylcholanthrene. The particular dihydrodiols that are the precursors of reactive diolepoxides have been identified, partly through the activities that they show as mutagens (Wood et al., 1976; Malaveille et al., 1977 Malaveille et al., , 1978 Levin et al., 1978) and as transforming agents (Marquardt et al., 1977 (Marquardt et al., , 1978 in in vitro tests, partly by the examination of the nucleic-acid adducts that are formed when the parent hydrocarbons are activated by metabolism in tissues or in cultured cells (Sims et al., 1974; Jeffrey et al., 1976 Jeffrey et al., , 1977 Tierney et al., 1977; Bigger et al., 1978) and partly by comparative in vivo tests for biological activity (Slaga et al., 1976; Chouroulinkov et al., 1976; Levin et al., 1976) . Since the non-K-region dihydrodiols are often available only in small amounts, many of the in vivo tests have been of tumour-initiating activity on mouse skin using a phorbol ester as a promoter, but other in vivo test procedures may merit investigation. The results presented here concern tests that have been carried out on the activities of dihydrodiols derived from 7-methylbenz [a] anthracene (I) or benzo [a] pyrene (II) (a) as tumour-initiating agents on mouse skin, (b) in the destruction of sebaceous glands and the induction of hyperplasia in mouse skin and (c) in the induction of s.c. sarcomas in rats. A preliminary report (Sims, 1967) . trans-1,2-Dihydro-1,2-dihydroxy
anthracene and trans-8,9-dihydro-8,9-dihydroxy-7-methylbenz[a]anthracene were obtained from oxidations of the parent hydrocarbon with an ascorbic acid-EDTA-ferrous sulphate mixture and characterized as described , and trans-5,6-dihydro-5,6 -dihydroxy -7 -methylbenz[a]anthracene and trans-4,5-dihydro-4,5-dihydroxybenzo [a] pyrene were prepared from the corresponding cis-isomers (Sims, 1967 (Sims, , 1970 Guerin & Cuzin (1961) and by Lazar et al. (1963 Lazar et al. ( , 1974 was followed. Female 45-day-old CDI mice were randomized into groups and housed individually. An acetone solution (0.05 ml) of either benzo [a] pyrene or of one of the 3 related transdihydrodiols was then applied to an area of dorsal skin that had been closely clipped 3 days earlier. The treatment was repeated on alternate days until a total of 3 applications of the test substance had been made to each mouse; a control group was treated with 3 applications of acetone alone. Eight days after the first treatment, the mice were killed and the areas of treated skin fixed, sectioned and stained for histological examination. The thickness of the epidermis and the numbers of sebaceous glands present were determined in 2 microscopic fields of each of 6 sections that were cut from each skin specimen. The microscopic examinations were carried out on code-numbered slides that carried no details of the treatment given.
Subcutaneous effects in rats.-Female 6-week-old Wistar rats (Evic-Ceba, Bordeaux, France) were randomized into groups of 32 and housed 8 to a cage. The animals received a single s.c. injection (0-9 mg) of either benzo-377 378 I. CHOUROULINKOV, A. GENTIL, B. TIERNEY, P. L. GROVER AND P. SIMS
[a]pyrene or of one of the 3 related transdiols in olive oil (0 5 ml) in the dorsal region, and were then kept under observation without further treatment for up to 9 months. Postmortem and histological examinations were done when the animals died or were killed.
RESULTS
The data from the mouse-skin tumour initiation-promotion experiments using either 7-methylbenz[a]anthracene or one of the related trans-1,2-, trans-3,4-, trans-5,6 ortrans-8,9-dihydrodiols as initiating agents are given in Table I , which summarizes information on the times at which tumours appeared, on the numbers of mice bearing tumours and on the frequency with which neoplasms occurred in each group of animals. Papillomas, the predominant tumour type, started to appear about 10 weeks after initiation, as in previous experiments (Chouroulinkov et al., 1976) , and they appeared first in the group of mice initiated with the 3,4-dihydrodiol. Only 5 malignant neoplasms were found, 4 of which were squamous-cell carcinomas, and the earliest examples of this type oftumour were detected in mice initiated with the 3,4-dihydrodiol. The other malignant tumour was a mixed-cell tumour that contained both epithelial and fibroblastic elements. At the termination of the experiments, postmortem examinations also revealed 13 animals with lung adenomas, 1 with a uterine fibrosarcoma and 1 with a thymic lymphoma, but the distribution of animals bearing these tumours did not appear to be related to the treatments that the mice had received.
The skin-tumour incidence in the mice initiated with the 3,4-dihydrodiol increased sharply, but reached a plateau at around 20 weeks after initiation; a second plateau occurred after 40 weeks. The numbers of tumours in the group of mice initiated with 7-methylbenz[a]anthracene itself increased more regularly, and showed only one plateau, after the 40th week. In contrast, tumour development in the mice initiated with the related 1,2-and 8-9-dihydrodiols only really increased after the amount of TPA applied had been doubled to 10 Hg per application. The 5,6-dihydrodiol was almost without activity; after the amounts of TPA applied were increased, 3 papillomas appeared in this group, but 2 of these later regressed.
The relative initiating activities of the compounds tested were evaluated using the x2 test, which confirmed that the 3,4-dihydrodiol was the most active compound. Although the number of animals with tumours was not significantly different between the groups initiated with the 3,4-dihydrodiol and with the parent hydrocarbon, the total number oftumours resulting from initiation by this diol is significantly greater ( P<0 05) in the groups injected with either the 4,5-or the 9,10-dihydrodiols, and only one sarcoma was induced in the group of rats injected with the 7,8-dihydrodiol. All the tumours that occurred were first detected during the 6th month after the injection. They were classical s.c. tumours that evolved slowly, and the tumourbearing animals that died or were killed 8-9 months after the start of the experiment carried large tumours. Postmortem and histological examinations showed that the tumours were fibrosarcomas with well-limited margins that had not metastasized; no other tumours were found in the rats when the experiment was terminated at 9 months.
DISCUSSION
The results (Table I) when 7-methylbenz[a]anthracene and 4 related dihydrodiols were tested for tumour-initiating activity on mouse skin clearly show that the 3,4-dihydrodiol is more active in this respect than the parent hydrocarbon, which is itself more active than the related 1,2-, 5,6-and 8,9-dihydrodiols. The 10,11-dihydrodiol was not tested in these experiments because it was not available in sufficient quantity. The 1,2-and 8,9-dihydrodiols are, like the 3,4-dihydrodiol, non-K-region diols that possess an isolated double bond adjacent to the diol grouping and they can in theory be converted into vicinal diol-epoxides: a diol-epoxide of this type cannot be directly formed, however, from the K-region diol (the 5,6-dihydrodiol), which was essentially devoid of tumour-initiating activity in the present experiments (Table I ). The high initiating activity of the 3,4-dihydrodiol is in agreement with other data from biophysical (Vigny et al., 1977) , biochemical and biological (Malaveille et al., 1977; Marquardt et al., 1977) studies, which together strongly suggest that the metabolic activation of this hydrocarbon involves the 3,4-dihydrodiol and its conversion into the related vicinal diol-epoxides, the isomeric 3,4-dihydro-3,4 -dihydroxy -7 -methylbenz[a]anthracene, 1,2-oxides. 7-Methylbenz[a]anthracene is metabolized by mouse skin to a variety of hydroxylated products that include the 3,4-dihydrodiol and, in the present experiments, the lower activity of the parent hydrocarbon than of the 3,4-dihydrodiol, may well reflect its metabolism by alternative pathways.
The results reported here for dihydrodiols derived from 7-methylbenz[a] anthracene and those obtained previously for diols derived from benzo[a]pyrene (Slaga et al., 1976; Chouroulinkov et al., 1976; Levin et al., 1976) and from benz [a] anthracene (Levin et al., 1978) show that comparative tests for mouse-skin tumourinitiating activity can assist in the identification of the dihydrodiols that are involved in the metabolic activation of the parent hydrocarbons.
In contrast, the results when the activities of benzo[a]pyrene and of its related dihydrodiols in the induction of hyperplasia and the suppression of sebaceous glands in mouse skin and in the induction of s.c. sarcomas in rats were examined were not so encouraging. In these shortterm mouse skin tests (Table II) (Malaveille et al., 1975; Slaga et al., 1976; Chouroulinkov et al., 1976; Marquardt et al., 1976) , was clearly less active than the parent hydrocarbon. The activities of a range of polycyclic hydrocarbons in inducing hyperplasia and in suppressing sebaceous glands have been reported to correlate with their carcinogenic potencies (Bock & Mund, 1958; Gue'rin & Cuzin, 1961; Lazar & Chouroulinkov, 1974) .
Somewhat similar results were obtained when the carcinogenic activities of benzo-[a]pyrene and the related dihydrodiols were compared after their s.c. injection into rats (Table III) . Although the 7,8-dihydrodiol produces tumours in mouse skin, and is as active in this respect as the parent hydrocarbon, it was very much less active than benzo[a]pyrene as an s.c. carcinogen in rats. Since it has been shown that shortterm skin tests in mice are more relevant to the promoting activities of chemicals (Lazar & Chouroulinkov, 1974) and since the induction of s.c. sarcomas in rats appears to be related to the abilities of chemicals to act as complete carcinogens, the lack of activity shown by the 7,8-dihydrodiol of benzo[a]pyrene in these tests and the high activity that it has shown in other test systems suggests that it may be more effective as an initiating agent than as a complete carcinogen. However, this explanation requires experimental confirmation, and the differences between the activities of benzo[a]pyrene and of the related 7,8-dihydrodiol in the two test systems examined here may be due to pharmacokinetic differences in the metabolism of these compounds in these situations. Of the 3 test systems examined here, therefore, only the mouse skin initiation-promotion experiments have given results that are in broad agreement with the other available information that has identified the 7,8-dihydrodiol of benzo [a] pyrene and the 3,4-dihydrodiol of 7-methylbenz[a]anthracene as the dihydrodiols that are, through conversion into reactive bay-region vicinal diolepoxides, important in the metabolic activation of these two carcinogenic hydrocarbons.
